Moderna’s two-strain shot will target both the original Covid-19 strain and BA.1 in step with European regulators
该疫苗针对新冠病毒原始毒株和Omicron BA.1亚型毒株。此举为英国使用这款疫苗开展秋季加强剂接种工作奠定基础。
The Medicines and Healthcare products Regulatory Authority — which was the first in the world to approve an original Covid-19 jab — has granted a conditional authorisation to the vaccine, which targets both the original strain of the virus and Omicron BA.1.
该疫苗针对新冠病毒原始毒株和Omicron BA.1亚型毒株。英国药品和保健品监管局(MHRA)——全球首个批准原始新冠疫苗的监管机构——已给予这款疫苗有条件授权。
The vaccine is authorised for use in people aged 18 or over but the UK plans to focus its booster programme to prepare for rising cases over the winter on the over 50s and those at higher clinical risk of developing severe Covid-19.
该疫苗获准用于18岁或以上的人群，但英国的加强剂接种计划拟聚焦于50岁以上人群以及有较高临床风险罹患新冠重症的人群，以求针对冬季病例增加的前景做好准备。
该疫苗针对新冠病毒原始毒株和Omicron BA.1亚型毒株。此举为英国使用这款疫苗开展秋季加强剂接种工作奠定基础。
该疫苗针对新冠病毒原始毒株和Omicron BA.1亚型毒株。英国药品和保健品监管局(MHRA)——全球首个批准原始新冠疫苗的监管机构——已给予这款疫苗有条件授权。
The vaccine is authorised for use in people aged 18 or over but the UK plans to focus its booster programme to prepare for rising cases over the winter on the over 50s and those at higher clinical risk of developing severe Covid-19.
该疫苗获准用于18岁或以上的人群，但英国的加强剂接种计划拟聚焦于50岁以上人群以及有较高临床风险罹患新冠重症的人群，以求针对冬季病例增加的前景做好准备。
